Ttrap is a novel component of the non-canonical TRAF6-TAK1 TGF-β signaling pathway

16Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Transforming growth factor-β (TGF-β) principally relays its effects through the Smad pathway however, accumulating evidence indicate that alternative signaling routes are also employed by this pleiotropic cytokine. For instance recently, we have demonstrated that ligand occupied TGF-β receptors can directly trigger the TRAF6-TAK1 signaling module, resulting in MAP kinase activation. Here we report identification of the adaptor molecule TTRAP as a novel component of this non-canonical TGF-β pathway. We show that the protein associates with TGF-β receptors and components of the TRAF6-TAK1 signaling module, resulting in differential regulation of TGF-β activated p38 and NF-κB responses. Modulation of cellular TTRAP level affects cell viability in the presence of TGF-β, suggesting that the protein is an important component of the TGF-β induced apoptotic process. © 2011 Várady et al.

Cite

CITATION STYLE

APA

Várady, G., Sarkadi, B., & Fátyol, K. (2011). Ttrap is a novel component of the non-canonical TRAF6-TAK1 TGF-β signaling pathway. PLoS ONE, 6(9). https://doi.org/10.1371/journal.pone.0025548

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free